Back to Journals » Journal of Blood Medicine » Volume 11

An Open-Label Extension Study to Assess the Long-Term Efficacy and Safety of a Plasma-Derived von Willebrand Factor (VWF)/Factor VIII (FVIII) Concentrate in Patients with von Willebrand Disease (SWIFT-VWDext Study)

Total article views   HTML views PDF downloads Totals
4,683 Dovepress* 4,279+ 787 5,066
PubMed Central* 404 319 723
Totals 4,683 1,106 5,789
*Since 9 October 2020

View citations on PubMed Central and Google Scholar